Results 31 to 40 of about 40,373 (162)

La mercantilización del derecho a la salud: patentes farmacéuticas

open access: yesDeusto Journal of Human Rights, 2017
In spite of the great developments in medicine in the 20th century, the healthcare and the quality of life of millions of people living in developing countries are still under the acceptable limits.
Lourdes Collado Rodríguez
doaj   +1 more source

Benign by design: A paradigm shift in cosmetic ingredient development

open access: yesInternational Journal of Cosmetic Science, EarlyView.
Benign by design strategies enable the creation of biodegradable cosmetic ingredients, reducing environmental persistence while maintaining the intended biological activity. This work compiles design rules and tools to guide the development of more sustainable molecules for the cosmetics industry.
Sandra Mota   +3 more
wiley   +1 more source

Os tratados de livre comércio e o acordo TRIPS: uma análise de proteção patentária na área farmacêutica [PDF]

open access: yes, 2009
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Jurídicas. Programa de Pós-graduação em DireitoA adesão ao Acordo sobre Aspectos dos Direitos de Propriedade Intelectual relacionados ao Comércio (Acordo TRIPS) em 1994 ...
Silva, Francisco Viegas Neves da
core  

Patentes farmacéuticas en Brasil y T-MEC. Aproximaciones de dos regulaciones

open access: yesBoletín Mexicano de Derecho Comparado
Las patentes son un privilegio temporal previstas en las legislaciones internacionales, acuerdos de libre comercio y en el derecho interno. Derivadas de las invenciones, necesitan cumplir requisitos fundamentales para solicitarse.
Marta Carolina Giménez Pereira   +2 more
doaj   +1 more source

Sharing the Burden: The Impacts of Pharmacy Sector Reforms on the Labor Market for Pharmacists in Portugal

open access: yesIndustrial Relations: A Journal of Economy and Society, EarlyView.
ABSTRACT During the 2010 crisis, the Portuguese government enacted several reforms to its prescription drug reimbursement system. As a result, value added per pharmacist in pharmacies fell by a third. We use longitudinal records from Quadros de Pessoal (QP), merged with collective bargaining data and firm financial records, to study the impacts of the ...
David Card   +2 more
wiley   +1 more source

REGULAÇÃO DE PRODUTOS PARA SAÚDE: EM BUSCA DAS MELHORES PRÁTICAS

open access: yesRevista de Direito Sanitário, 2017
A seção "Tema em Debate" deste número da Revista de Direito Sanitário centra-se novamente no marco regulatório existente no Brasil na área de produtos para a saúde.
Daniela Trejos Vargas
doaj   +1 more source

Changes in serum β‐synuclein precede blood biomarkers of Alzheimer pathology in Down syndrome

open access: yesAlzheimer's &Dementia, Volume 22, Issue 9, September 2026.
Abstract INTRODUCTION There is a need for early, objective markers of Alzheimer's disease (AD)‐related synapse dysfunction in adults with Down syndrome (DS). The presynaptic protein β‐synuclein is elevated in the blood of adults with DS. This study evaluates the positioning of these changes relative to changes in pathophysiological blood biomarkers ...
Alba Cervantes González   +23 more
wiley   +1 more source

Methamphetamine Enantiomers: From Chemical Synthesis to Biological Fate

open access: yesChirality, Volume 38, Issue 9, September 2026.
Methamphetamine is an amphetamine‐type stimulant characterized by a single stereogenic center, resulting in two enantiomers, (R)‐(−)‐methamphetamine and (S)‐(+)‐methamphetamine, with distinct biological and pharmacological profiles. These forms exhibit differences in central nervous system activity, metabolism, excretion, and overall physiological ...
Larissa Pires do Espírito Santo   +9 more
wiley   +1 more source

CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults

open access: yesAlzheimer's &Dementia, Volume 22, Issue 8, August 2026.
Abstract INTRODUCTION Blood–brain barrier (BBB) dysfunction is an early feature of Alzheimer's disease (AD). Fibrinogen represents a sensitive marker of BBB leakage, but whether it modifies longitudinal tau progression in cognitively unimpaired (CU) individuals remains unknown.
Christos Panagiotis Lisgaras   +21 more
wiley   +1 more source

Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus

open access: yesClinical and Translational Allergy, Volume 16, Issue 8, August 2026.
Expert consensus using a Delphi methodology proposed definitions of control and remission for allergic rhinitis, conjunctivitis and asthma in the context of allergen immunotherapy. These consensus‐based criteria integrate symptoms, medication use, patient‐reported outcomes and objective measures to support a more structured assessment of treatment ...
Eloína González‐Mancebo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy